======================================================================
India's Pharmacy War: 12.4 Lakh Chemists vs The E-Pharmacy Juggernaut
May 20, 2026. Every medicine shop in India — all 12.4 lakh of them — pulled down its shutters.
The All India Organisation of Chemists and Druggists (AIOCD) called a nationwide bandh, and for once, the streets outside your neighbourhood pharmacy fell silent. Not because medicines ran out. But because the men and women who dispensed them for decades finally said: enough.
The spark: discounts that defy the law
At the heart of the dispute are the steep discounts offered by online pharmacy platforms. According to the AIOCD, discounts ranging from 20% to 60% are being extended to consumers — levels it claims are not viable under existing regulatory norms. The National Pharmaceutical Pricing Authority (NPPA) permits a retail margin of around 16%. Online players burn capital to offer multiples of that, squeezing independent chemists who must play by the old rules. Outlook India
The strike highlights economic challenges for India's many independent chemists, who hold about 54% of the retail pharmacy market. Rural and semi-urban chemists face the greatest risk, as neighbourhood pharmacies in these areas often serve as the first and only accessible healthcare point. The AIOCD estimates that the livelihoods of 50 million people are tied to the pharmacy retail trade. Whalesbook
It's not just about money — it's about fake prescriptions
In February 2026, a Times of India investigation found that online pharmacy platforms accepted AI-generated prescriptions with fabricated hospital names and doctor details, and dispensed psychotropic drugs, opioids, antibiotics, and some banned medicines. MEDIANAMA
Three patient safety gaps stand out: AI-generated prescriptions bearing fabricated hospital and doctor details clear verification on online platforms, which lack human oversight to detect forgeries; prescription reuse, which allows the same scanned prescription to procure antibiotics and habit-forming drugs repeatedly, with no central registry to flag duplicates; and unverified antibiotic access, which accelerates antimicrobial resistance — a threat the WHO has flagged as one of the top ten global public health threats. Physical chemists must verify prescriptions before dispensing medicines under Drug Rule 65 of the Drugs and Cosmetics Rules, 1945. Online pharmacies carry no equivalent legal obligation. MEDIANAMA
The legal grey zone — eight years in the making
AIOCD President Jagannath S. Shinde has pointed out that there is currently no provision under the Drugs and Cosmetics Act, 1940 permitting online sale of medicines. Despite this, e-pharmacies have expanded rapidly and now operate in a legal grey zone. The Central Government issued a notification under GSR 817(E) in 2018 regarding online medicine sales, but it was never converted into law. A writ petition is pending before the Delhi High Court, which has also granted a stay on online medicine sales — a stay that is being routinely ignored in practice. Hindustan Herald
From 2025 onwards, rules remain unnotified, while Blinkit, Zepto, and Swiggy Instamart have begun prescription medicine delivery without e-pharmacy licences. MEDIANAMA
A visionary saw this coming — in 2015
What makes this story richer is that a prescient Mumbai-based thinker, Hemen Parekh, had mapped this very crisis and its solution a full decade ago.
Writing in December 2016, Parekh argued that the online sale of medicines was "unstoppable" and that the opportunity lay not in prohibition, but in building a Comprehensive Healthcare Eco-System. As far back as October 2015, he had proposed a government-built mobile app — he called it "DISPENSER" — that would digitally track every step of a prescription: doctor to patient to chemist, with every transaction automatically emailed to the Health Ministry, the Drug Controller General, AIOCD, and the All India Medical Association. The benefits he outlined were ahead of their time: no chance of misreading a doctor's handwriting, full drug history for every patient, and complete transparency for every chemist shop and prescribing doctor. blogspot
Had that vision been adopted, we might not be here today.
Where things stand
In a memorandum submitted to Prime Minister Narendra Modi, the AIOCD has made it clear that despite repeated requests, no concrete action has been taken on the serious issues affecting the pharmaceutical trade. AIOCD President J. S. Shinde and General Secretary Rajiv Singhal have jointly stated: "This is not merely a matter of trade, but of patient safety. If the Government does not take any concrete decision on these demands by May 20, we will be compelled to launch an indefinite agitation." ANI News
Key e-pharmacies include Tata 1mg (31% market share in early 2026), Apollo 24|7 (28%), PharmEasy (15%), and Netmeds (7%). India's pharmaceutical market is predicted to hit $79.74 billion by 2031, relying on both traditional and online channels. Whalesbook
The regulator must choose. The chemist at the corner of your street, and the patient who depends on him, are both waiting.
Sources: AIOCD press releases · Outlook India · MediaNama · ANI · Hemen Parekh blog (myblogepage.blogspot.com, 2016)
No comments:
Post a Comment